The U.S. Food and Drug Administration has announced a final rule to update the definition of the nutrient content claim “healthy.”
According to the FDA, there is an ever-growing
The FDA Foods Coalition was announced Thursday in Washington, D.C., promising to put more pressure on the federal government for improved food safety.
Since February 2022, when Dr. Robert
When consumer and environmental groups went to California to ban certain ingredients from food, they hoped to get the FDA’s support for national action.
But food manufacturers are also
Dr. Susan Mayne, who leaves government on May 31, has told the Alliance for a Stronger FDA, that the Center for Food Safety and Applied Nutrition (CFSAN) she has led
In the recent inaugural of his “Catching Up with Califf” blog, FDA Commissioner Robert M. Califf called attention to the Global Food Security Index. Including measures for Quality and Safety,
— OPINION —
How food safety is best organized in a country this big and this populous is the question we should be asking. Instead during the past confusing year, we’ve
During the same week that the Food and Drug Administration re-affirmed its approval of Atlantic salmon with an intentionally altered genome, the agency also permitted the growth of chicken from
Were it not for all the meetings about infant formula, FDA Commissioner Robert M.Califf’s schedule would look like those of his many predecessors, emphasizing drugs and medical devices.
The question members of a Senate subcommittee wanted answered by FDA officials involved how to make food safety a priority at the agency. The FDA commissioner said much of the
UPDATED — This version of this story includes quotes from Commissioner Robert Califf and U.S. Rep. Rosa Delauro.
A shakeup of the chain of command at the FDA may be
Editor’s Note: FDA Commissioner Robert M. Califf delivered remarks in June to the FDLI Annual Conference. Here are excerpts from his prepared remarks that addressed food safety.
“One issue
It’s that time of year when agency and department heads appear before Congressional committees to discuss their budget requests. For FDA Commissioner Robert M. Califf, M.D. that means
